Prevention of the SuicideC-SIAMNCT03069560
Short Message System (SMS) for Caregivers of Suicidal Patients to Prevent Recidivism of Suicide Attempts
A study testing SMS in people with Prevention of the Suicide, run by University Hospital, Brest at 1 site in France.
Trial summary
Assessment of the feasibility of a monitoring device by SMS in which messages are sent by the caregiver after a suicidal act. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Prevention of the Suicide
- What is being tested?
- SMS
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 15 participants
- Where
- 1 siteFrance
- Study dates
- 19 Jul 2017to 8 Aug 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Male or female, over 18 years of age and hospitalized;
- Survivor of a suicide attempt;
- Giving informed, dated and signed consent;
- Can be reached by mobile phone. The study is proposed to all adult suicides and to the patient's designated caregiver, meeting the inclusion criteria.
Who cannot join
- Patient whose clinical condition is incompatible with the formulation of his non-opposition.
- The patient and his / her caregiver shall not be afforded a protective justice measure.
Trial locations and contacts
1 site in 1 country.
About this study
Assessment of the feasibility of a monitoring device by SMS in which messages are sent by the caregiver after a suicidal act.
- Conditions
- Prevention of the Suicide
- Being tested
- SMS
- Keywords
- suicide attempt, SMS monitoring, Phone, Prevention control, tertiary healthcare
- Medical subject headings
- Suicide, Attempted
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SMSDevice
SMS contact from the caregiver with patient after discharge in intervention group
| Study group | Role | What they receive |
|---|---|---|
| SMS | Experimental | The patients will receive from the caregiver a first SMS 48 hours after their discharge from the hospital then a total of 4 messages : 48 hours, S1, S2, and S4. Receives: Device: SMS |
What is being measured
The primary outcome is the main question the study is designed to answer.
Measurement of the feasibility of the device by the patient according to a validated questionnaire
The primary endpoint is the measurement of the feasibility of the device by the patient based on a validated questionnaire. This evaluation will take place during the medical interview that will close the study participation.
Measured: 6 months
Secondary outcomes (3)
The questionnaire measuring the feasibility for the caregiver of such a device
A questionnaire will be provided to the caregiver to measure the feasibility of such a device
Measured: 6 months
Questionnaires on the acceptability of patients and caregivers in relation to the use of this type of monitoring device
Acceptability questionnaires will be provided to patients and caregivers in relation to the use of this type of monitoring device
Measured: 6 months
Qualitative analysis of messages sent to patients during the study.
A qualitative analysis of the messages addressed to the patients during the study will be carried out.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Mar 2017
- Study start19 Jul 2017
- Primary completion8 Aug 2019
- Study completion8 Aug 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Prevention of the SuicideStudies of the same condition, open and under way.
- More trials run by University Hospital, BrestThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 15 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Brest
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03069560
- Sponsor's protocol ID
- C-SIAM (29.BRC.16.115)
- Acronym
- C-SIAM
- Status last verified
- May 2020
- First submitted
- 28 Feb 2017
- Last updated
- 3 Dec 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Le Moal V, Lemey C, Walter M, Berrouiguet S. Viewpoint: Toward Involvement of Caregivers in Suicide Prevention Strategies; Ethical Issues and Perspectives. Front Psychol. 2018 Dec 18;9:2457. doi: 10.3389/fpsyg.2018.02457. eCollection 2018. No abstract available.
PubMed 30618917
Study at a glance
From the registry record, last updated by the sponsor on 3 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Short Message System (SMS) for Caregivers of Suicidal Patients to Prevent Recidivism of Suicide Attempts
- ClinicalTrials.gov ID
- NCT03069560
- Acronym / sponsor ID
- C-SIAM / C-SIAM (29.BRC.16.115)
- Conditions
- Prevention of the Suicide
- Keywords
- suicide attempt, SMS monitoring, Phone, Prevention control, tertiary healthcare
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 15 participants (actual)
- Lead sponsor
- University Hospital, BrestUniversity, hospital or other
- Study start
- 19 Jul 2017 (actual)
- Primary completion
- 8 Aug 2019 (actual)
- Study completion
- 8 Aug 2019 (actual)
- First posted
- 3 Mar 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Assessment of the feasibility of a monitoring device by SMS in which messages are sent by the caregiver after a suicidal act.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| SMS | Experimental | Device: SMSThe patients will receive from the caregiver a first SMS 48 hours after their discharge from the hospital then a total of 4 messages : 48 hours, S1, S2, and S4. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Male or female, over 18 years of age and hospitalized;
- Survivor of a suicide attempt;
- Giving informed, dated and signed consent;
- Can be reached by mobile phone. The study is proposed to all adult suicides and to the patient's designated caregiver, meeting the inclusion criteria.
Key exclusion criteria (2 listed)
- Patient whose clinical condition is incompatible with the formulation of his non-opposition.
- The patient and his / her caregiver shall not be afforded a protective justice measure.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SMSSMS contact from the caregiver with patient after discharge in intervention group | Device | SMS |
Primary outcome
Measurement of the feasibility of the device by the patient according to a validated questionnaire
Time frame: 6 months
The primary endpoint is the measurement of the feasibility of the device by the patient based on a validated questionnaire. This evaluation will take place during the medical interview that will close the study participation.
3 secondary outcomes
The questionnaire measuring the feasibility for the caregiver of such a device
Time frame: 6 months
Questionnaires on the acceptability of patients and caregivers in relation to the use of this type of monitoring device
Time frame: 6 months
Qualitative analysis of messages sent to patients during the study.
Time frame: 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Dec 2025.
- Background: PubMed 30618917Le Moal V, Lemey C, Walter M, Berrouiguet S. Viewpoint: Toward Involvement of Caregivers in Suicide Prevention Strategies; Ethical Issues and Perspectives. Front Psychol. 2018 Dec 18;9:2457. doi: 10.3389/fpsyg.2018.02457. eCollection 2018. No abstract available.
Related trials for Prevention of the Suicide
Recruiting
Exploring The Effect of TikTok Trigger Warnings in a Clinical Sample of Youth at Risk of Suicide
Suicide Prevention, Social Media Users
Not yet recruitingPhase 1/2
Reducing Firearm Suicide Among Veterans: Evaluating the Effectiveness of Peer-Delivered Lethal Means Counseling
Suicide, Secure Firearm Storage
Not yet recruitingPhase 2
Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of Stay
Suicidal Ideation, Suicidal Behavior
Recruiting
Development of a Treatment Prognosis Calculator for the Prevention of Suicide
Suicidal Ideation
RecruitingPhase 2/3
Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
Suicide
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing SMS in people with Prevention of the Suicide, run by University Hospital, Brest at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Measurement of the feasibility of the device by the patient according to a validated questionnaire (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03069560, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2025.